|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/519 | (2006.01) |
| A61K 31/454 | (2013.01) | ||
| A61K 31/573 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/454 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/573 | (2013.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/02 | (2018.01) |
| (11) | Patento numeris | 3148545 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15800211.3 |
| Europos patento paraiškos padavimo data | 2015-05-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-04-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-03-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/032869 |
| Data | 2015-05-28 |
| (87) | Numeris | WO 2015/184087 |
| Data | 2015-12-03 |
| (30) | Numeris | Data | Šalis |
| 201462004061 P | 2014-05-28 | US |
| (72) |
BERENSON, James R. , US
|
| (73) |
Onco Tracker, Inc. ,
9201 Sunset Boulevard, Suite 300, West Hollywood, CA 90069,
US
|
| (54) | ANTI-CANCER EFFECTS OF JAK2 INHIBITORS IN COMBINATION WITH THALIDOMIDE DERIVATIVES AND GLUCOCORTICOIDS |
| ANTI-CANCER EFFECTS OF JAK2 INHIBITORS IN COMBINATION WITH THALIDOMIDE DERIVATIVES AND GLUCOCORTICOIDS |